Tong Ren Tang Technologies (HKG:1666) renewed a trademark license agreement with Tong Ren Tang Chinese Medicine (HKG:3613) for three years from Jan. 1, 2025, to Dec. 31, 2027, a Monday bourse filing said.
Under the contract, the firm will continue to have permission to use the "Tong Ren Tang" trade name and certain trademarks of medicine maker Tong Ren Tang Chinese Medicine.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.